| Electrophysiological maturation of cerebral organoids correlates with dynamic morphological and cellular development SR Fair, D Julian, AM Hartlaub, ST Pusuluri, G Malik, TL Summerfied, ... Stem cell reports 15 (4), 855-868, 2020 | 117 | 2020 |
| Modeling human brain circuitry using pluripotent stem cell platforms AM Hartlaub, CA McElroy, NL Maitre, ME Hester Frontiers in Pediatrics 7, 57, 2019 | 24 | 2019 |
| CuATSM effectively ameliorates ALS patient astrocyte‐mediated motor neuron toxicity in human in vitro models of amyotrophic lateral sclerosis CN Dennys, F Roussel, R Rodrigo, X Zhang, A Sierra Delgado, ... Glia 71 (2), 350-365, 2023 | 13 | 2023 |
| In vitro modeling for neurological diseases using direct conversion from fibroblasts to neuronal progenitor cells and differentiation into astrocytes CN Dennys, JA Sierra-Delgado, SS Ray, AM Hartlaub, FS Roussel, ... JoVE (Journal of Visualized Experiments), e62016, 2021 | 11 | 2021 |
| Patient-derived organoids recapitulate intrinsic immune landscapes and progenitor populations of glioblastoma F Watanabe, EW Hollingsworth, JM Bartley, L Wisehart, R Desai, ... biorxiv, 2021.10. 06.463228, 2021 | 4 | 2021 |
| Patient-derived organoids recapitulate glioma-intrinsic immune program and progenitor populations of glioblastoma F Watanabe, EW Hollingsworth, JM Bartley, L Wisehart, R Desai, ... PNAS nexus 3 (2), pgae051, 2024 | 1 | 2024 |
| Multicenter AAV Gene Therapy Studies for SMARD1/CMT2S Establish Safety and Efficacy in Multiple Animal Models and Pave the Way for Initiation of a Phase I/II Clinical Trial JAS Delgado, S Likhite, SE Holbrook, V McGovern, D Chung, J Caporale, ... MOLECULAR THERAPY 30 (4), 17-18, 2022 | | 2022 |
| Modeling of SCN2A Related Disorders In Vitro Allows Exploration of Disease Mechanism and Identification of Potential Therapies for This Neurological Disease Y Rodriguez, C Dennys, A Hartlaub, T Bedrosian, S Fair, J Kearney, ... MOLECULAR THERAPY 29 (4), 285-286, 2021 | | 2021 |
| Rapid reprogramming of ALS patient fibroblasts differentiates CuATSM responders from nonresponders. C Dennys, F Roussel, X Zhang, R Rodrigo, A Hartlaub, A Sierra-Delgado, ... MDPI, 2020 | | 2020 |
| Development of Therapeutic Strategies for SCN2A Mutation Related Disorders Using New In Vitro Modeling Techniques Y Rodriguez, C Dennys-Rivers, SS Ray, F Roussel, R Rodrigo, D Lesman, ... MOLECULAR THERAPY 28 (4), 484-484, 2020 | | 2020 |
